20-08-2010

American Peptide Company announced the addition of two key positions within the company. These appointments, which are comprised of a new sales account executive for the East Coast region of the United States and a sales & marketing director for Europe, will allow the peptide contract ...

more

05-05-2010

In a slow economy, pharmaceutical and biotech companies facing increasing pressure to reduce costs, risk, and time-to-market, and maximize efficiencies have converged on a sound business strategy: outsource non-core functions such as peptide manufacturing. To help meet rising outsourcing ...

more

25-06-2009

American Peptide Company announced the appointment of Firuz Shakoori as Sales Director, who has been responsible for new business development since January 2009. Mr.Shakoori will work closely with customers as their drug products move from discovery to development and commercialization. In ...

more

Company expands capacity to accommodate large scale peptide production for growing customer base

29-01-2009

American Peptide Company, Inc. announced the expansion of its state-of-the-art GMP peptide manufacturing facility in Vista, California. The facility expansion will increase the company’s large-scale peptide production capacity as well as enable it to continue to provide high quality peptides ...

more

Acquisition Offers American Peptide Company Access to Greater Resources

01-08-2008

American Peptide Company, Inc. announced that its parent company, Ito Life Sciences (Ibaraki, Japan), will be acquired by Otsuka Chemical Company (Osaka, Japan), part of the Otsuka Group (Osaka, Japan). Otsuka Chemical Company will be the new owner of American Peptide Company and Ito Life ...

more